
OCULAR THERAPEUTIX INC
OCULNASDAQ๐ #1497 by market capEarnings Nov 2 ยท PostUS Equity
$9.76โฒ $0.55 (+5.63%)
Live1hโ
24hโฒ 5.6%
7dโ
14dโ
30dโ
1yโ
๐ฆMarket Cap
$2.14B
Small Cap
๐Revenue Growth (YoY)
-8.1%
Declining
๐Gross Margin
87.1%
High
๐ตFCF Margin
โ
โ๏ธP/S Ratio
38.8x
Expensive
Otter Score
62
Fair
Earnings
Q3 ยท 2026Reported 2026-08-03Earnings Per Share
Actual
-0.35
Expected
-0.40
beat
+11.50%
YoY +10.30%
Revenue
Actual
$13.47M
Expected
$13.20M
beat
+2.10%
YoY +0.10%
Consensus estimates
Recent quarters
Q3 2026
-0.35
beat
Q2 2026
-0.41
miss
Q1 2026
-0.29
beat
Q4 2025
-0.37
beat